Heart disease is still the number one killer of Americans. Every year, hundreds of thousands of Americans who suffer heart attacks survive, but with a dramatically diminished quality of life. But now, the intersection of biotechnology and medical device development is making it possible to dramatically improve both long-term survival and quality of life for those who suffer serious heart attacks. Where does this technology stand? What are the implications for patients, investors, health care providers, and society in general?
- Getting Real About Synthetic Biology
- Globalization: The Wellspring of Global Economic Growth